8-Chloro-2-(3-fluoroanilino)-5H-benzothiopyrano[4,3-d]pyrimidine

ID: ALA4243901

PubChem CID: 145982589

Max Phase: Preclinical

Molecular Formula: C17H11ClFN3S

Molecular Weight: 343.81

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Fc1cccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)c1

Standard InChI:  InChI=1S/C17H11ClFN3S/c18-11-4-5-14-15(6-11)23-9-10-8-20-17(22-16(10)14)21-13-3-1-2-12(19)7-13/h1-8H,9H2,(H,20,21,22)

Standard InChI Key:  CVQAYEOLNDZKLH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
   28.2949  -12.8604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2937  -13.6799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0018  -14.0889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0000  -12.4515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7086  -12.8568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7074  -13.6775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4136  -14.0865    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.1255  -13.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4159  -12.4452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1257  -12.8602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8378  -12.4531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8414  -11.6312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.1269  -11.2181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4177  -11.6276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.1272  -10.4009    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8350   -9.9925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5408  -10.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2482   -9.9978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2489   -9.1797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5363   -8.7711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8319   -9.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5857  -14.0880    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   33.9556  -10.4069    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  2 22  1  0
 18 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4243901

    ---

Associated Targets(Human)

MSTO-211H (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.81Molecular Weight (Monoisotopic): 343.0346AlogP: 5.29#Rotatable Bonds: 2
Polar Surface Area: 37.81Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.55CX Basic pKa: 1.51CX LogP: 5.22CX LogD: 5.22
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.69Np Likeness Score: -1.79

References

1. Salerno S, García-Argáez AN, Barresi E, Taliani S, Simorini F, La Motta C, Amendola G, Tomassi S, Cosconati S, Novellino E, Da Settimo F, Marini AM, Via LD..  (2018)  New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors.,  150  [PMID:29547832] [10.1016/j.ejmech.2018.03.013]

Source